| >Interested to hear your justification for declining / delaying vaccine I'm interested to hear why a five minute old infant is at risk of contracting Hep-B. Our kids will get Hep-B before they start school. Even if one of our kids did contract Hep-B, it is pretty unlikely that they will be able to give it to your children. Rota-virus vaccine was suspended by the FDA temporarily,[1] We opted to decline this one even after the suspension was lifted considering seriousness of intussusception[2][3] compared the very low incidence of death or serious injury by rota-virus infection in the US. Even though the suspension wasn't related to the earlier intussusception problem, I considered the incident sign of poor QC and/or a lack of respect for the FDA by the manufacturer. We would probably reconsider if we had plans for international travel with the children, even though our oldest has probably been exposed/infected. (a fun story!) (It sure would be nice if antibody testing were cheap and widely available). Seasonal Influenza - Declined based on personal negative experience and systematic reviews of vaccine efficacy[4][5]. Every single seasonal influenza vaccine I have taken has resulted in a miserable two-week flu-like state. I have never had a case of the flu as that was as unpleasant as my reaction to the vaccine. I understand most people are not affected so negatively by the vaccine. After reading the Cochrane reviews on the subject, I am inclined to believe that the seasonal Influenza vaccine is an unnecessary and rarely useful product. Not that I need to worry about it yet, but Cervarix and especially Gardasil seem to have low efficacy WRT to the (possible) risks of the vaccine, especially considering the prognosis for those that contract cervical cancer (women rarely die of cervical cancer). I also find Merck's relationship over the matter with my state's idiot Governor particularly aggravating. So, basically, if the risk of contracting and or having the illness is low, and if it doesn't needlessly endanger others (like MMR refusal for school-aged children) then I am going to take a good hard look at whether we really need the vaccine. >not considering yourself anti-vaccine. Anti-vaccine means you don't allow yourself or your children to be vaccinated. Our children do receive most vaccines at the scheduled time. We have opted to delay or forgo a few vaccines. Lumping people into two opposing factions has had a very negative effect on the debate, as it tends to do in a debate on any subject. [1] http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedP... [2] https://www.ncbi.nlm.nih.gov/pubmed/22293889 [3] http://www.fda.gov/BiologicsBloodVaccines/Vaccines/Questions... [4] 'Flu vaccine doesn't help elderly' http://www.ncbi.nlm.nih.gov/pubmed/20166072 [5] Please read the author's conclusions for this one. 'Vaccines for preventing influenza in healthy adults.' http://www.ncbi.nlm.nih.gov/pubmed/20614424 |
Because a baby whose mother is infected with Hep-B can be infected at birth, it's estimated that only 50% of the pregnant women who have Hep-B are identified, and babies can get Hep-B from other family members and caregivers.
See http://www.cdc.gov/mmwr/PDF/rr/rr5416.pdf for the full details, but here are two relevant passages:
> Even with improvements in the management of pregnant women, only approximately 50% of expected births to HBsAg-positive women are identified (on the basis of application of racial/ ethnic-specific HBsAg prevalence estimates to U.S. natality data) for case management, which maximizes timely delivery of postexposure immunoprophylaxis (11; CDC, unpublished data, 2004). The need for proper management of women without prenatal care, including HBsAg testing at the time of admission for delivery and administration of the first dose of vaccine to infants <12 hours of birth, is underscored by the higher prevalence of HBsAg seropositivity among these women than among women who are screened prenatally (12). Even when maternal HBsAg testing does occur, certain infants of HBsAg-positive mothers do not receive postexposure immunoprophylaxis because of testing errors and lapses in reporting of test results (13), and infants of women with unknown HBsAg status at the time of delivery often do not receive a birth dose of vaccine (14).
> Children who are not infected at birth remain at risk from long-term interpersonal contact with their infected mothers. In one study, 38% of infants who were born to HBsAg-positive mothers and who were not infected perinatally became infected by age 4 years (64). In addition, children living with any chronically infected persons are at risk for becoming infected through percutaneous or mucosal exposures to blood or infectious body fluids (e.g., sharing a toothbrush, contact with exudates from dermatologic lesions, contact with HBsAg-contaminated surfaces). HBV transmission rates to susceptible household contacts of chronically infected persons have varied (range: 14%–60%) (65,66). High rates of infection also have been reported among unvaccinated long-term residents of institutions for the mentally handicapped (67,68), and, in rare instances, person-to-person transmission has been reported in child care settings (69,70).
Also, the vaccine is made from virus capsid protein expressed in Baker's yeast. There's no infectious material at all, making it a very safe vaccine. (Unlike the earlier Hep-B vaccine which had a danger of including viral DNA should something go wrong during purification.)